Skip to content

eRegCom: communication strategies to healthcare providers and women from an electronic maternal and child health registry – a cluster randomized controlled trial

eRegCom: the effectiveness of performance feedback to healthcare providers and/or targeted client communication to pregnant and postpartum women, from an electronic maternal and child health registry, on improving effective coverage of care - a cluster randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10520687
Enrollment
138
Registered
2018-12-06
Start date
2018-10-22
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antenatal and postpartum care in public health services in Palestine, particularly the quality of care, the timely utilization of care, and the combination of the two, defined as effective coverage. To this end, five sentinel conditions, complications, and events in pregnancy are studied: anemia, hypertensive disorders in pregnancy, gestational diabetes mellitus, fetal growth restriction, and maternal attendance to care. Pregnancy and Childbirth

Interventions

The unit of randomization is public primary healthcare centers. All included public primary healthcare centers use the electronic maternal and child health registry system (MCH eRegistry). Details of

Sponsors

Norwegian Institute of Public Health
Lead Sponsor
Palestinian National Institute of Public Health, World Health Organization
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Public primary healthcare centers providing antenatal and postnatal services; currently active users of the national MCH eRegistry 2. There are no inclusion criteria on an individual basis

Exclusion criteria

Exclusion criteria: There are no eligibility criteria by individual healthcare providers or their client population characteristics

Design outcomes

Primary

MeasureTime frame
1. Comparison I: PFB arm vs Control arm: Appropriate screening and management of anemia, hypertensive disorders of pregnancy (HDP), gestational diabetes mellitus (GDM), and fetal growth restriction (FGR) 2. Comparison II: TCC arm vs Control arm: 2.1. Timely attendance to antenatal care visits 2.2. Retention rate from antenatal care to postpartum care 3. Comparison III: PFB + TCC (arm 3) vs Control arm: Timely attendance, appropriate screening, and management of anemia, hypertensive disorders of pregnancy, gestational diabetes mellitus, and fetal growth restriction. All the outcome measurements will be obtained from the MCH eRegistry monthly throughout the trial, data needed for these outcomes are continuously entered by the healthcare professionals at the point of care as a routine part of their documentation of care in clinical records.

Secondary

MeasureTime frame
1. Comparison I: PFB arm vs Control arm: 1.1. Timely screening for anemia 1.2. Timely screening for HDP 1.3. Timely screening for GDM 1.4. Timely screening for FGR 1.5. Appropriate management of anemia 1.6. Appropriate management of HDP 1.7. Appropriate management of GDM 1.8. Appropriate management of FGR 2. Comparison II: TCC arm vs Control arm: 2.1. Timely attendance for anemia screening 2.2. Timely attendance for HDP screening 2.3. Timely attendance for GDM screening 2.4. Timely attendance for FGR screening 3. Comparison III: PFB + TCC (arm 3) vs Control arm: 3.1. Timely attendance, screening, and management of anemia 3.2. Timely attendance, screening, and management of HDP 3.3. Timely attendance, screening, and management of GDM 3.4. Timely attendance, screening, and management of FGR All the outcome measurements will be obtained from the MCH eRegistry monthly throughout the trial, data needed for these outcomes are continuously entered by the healthcare professionals at the point of care as a routine part of their documentation of care in clinical records. The outcomes stated above will be stratified by equity quintiles.

Countries

Palestinian Territory

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 24, 2026